Skip to main content
AmigoFish

Ep. 82 – Act Now or Fall Behind: Michelle Rozo on Biotech’s National Security Stakes

From The BioCentury Show · · 31 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

The U.S. will cede its preeminence in biotechnology to China within three years unless the government acts urgently, an independent commission chartered by Congress warns. “Our window to act is closing,” the National Security Commission on Emerging Biotechnology said in a newly released report (https://www.biotech.senate.gov/final-report/chapters/). “We need a two-track strategy: make America innovate faster, and slow China down.” BioCentury Washington Editor Steve Usdin discusses the report's recommendations and warnings with the commission’s vice chair, Michelle Rozo, on The BioCentury Show.

View full story: https://www.biocentury.com/article/655654

#biotech #biopharma #pharma #lifescience #politics #policy #law

00:00 - Introduction 03:56 - China Closing the Innovation Gap 09:20 - Slowing China Down 17:20 - Bolstering U.S. Biotech

Back to The BioCentury Show · Report a problem